crc press - E-Lib FK UWKS

Transportans 69
and still retain efficient uptake. Moreover, transportan can deliver proteins in a native,
folded state of up to at least 150 kDa to the cytoplasm of living cells.
ACKNOWLEDGMENTS
This work was supported by grants from the EC Biotechnology Project BIO4-98-0227,
Swedish Research Councils TFR and NFR, and Estonian Science Foundation
(ESF4007).
REFERENCES
1. Derossi, D. et al., The third helix of the Antennapedia homeodomain translocates
through biological membranes, J. Biol. Chem., 269, 10444, 1994.
2. Vivés, E., Brodin, P., and Lebleu, B., A truncated HIV-1 Tat protein basic domain
rapidly translocates through the plasma membrane and accumulates in the cell
nucleus, J. Biol. Chem., 272, 16010, 1997.
3. Elliott, G. and O’Hare, P., Intercellular trafficking and protein delivery by a herpesvirus
structural protein, Cell, 88, 223, 1997.
4. Chaloin, L. et al., Conformations of primary amphipathic carrier peptides in membrane
mimicking environments, Biochemistry, 36, 11179, 1997.
5. Pooga, M. et al., Cell penetration by transportan, FASEB J., 12, 67, 1998.
6. Oehlke, J. et al., Cellular uptake of an alpha-helical amphipathic model peptide with
the potential to deliver polar compounds into the cell interior nonendocytically,
Biochim. Biophys. Acta., 1414, 127, 1998.
7. Langel, Ü. et al., A galanin-mastoparan chimeric peptide activates the Na + ,K + -ATPase
and reverses its inhibition by ouabain, Regul. Pept., 62, 47, 1996.
8. Land, T. et al., Linear and cyclic N-terminal galanin fragments and analogs as ligands
at the hypothalamic galanin receptor, Int. J. Pept. Protein. Res., 38, 267, 1991.
9. Langel, Ü., Land, T., and Bartfai, T., Design of chimeric peptide ligands to galanin
receptors and substance P receptors, Int. J. Pept. Protein. Res., 39, 516, 1992.
10. Consolo, S. et al., Galparan induces in vivo acetylcholine release in the frontal cortex,
Brain Res., 756, 174, 1997.
11. Östenson, C-G. et al., Galparan: a powerful insulin-releasing chimeric peptide acting
at a novel site, Endocrinology, 138, 3308, 1997.
12. Pooga, M. et al., Novel galanin receptor ligands, J. Pept. Res., 51, 65, 1998.
13. Heuser, J.E. and Anderson, R.G., Hypertonic media inhibit receptor-mediated endocytosis
by blocking clathrin-coated pit formation, J. Cell. Biol., 108, 389, 1989.
14. Lindgren, M. et al., Translocation properties of novel cell penetrating transportan and
penetratin analogues, Bioconjug. Chem., 11, 619, 2000.
15. Soomets, U. et al., From galanin and mastoparan to galparan and transportan, Curr.
Top. Pept. Protein. Res., 2, 83, 1997.
16. Higashijima, T. et al., Conformational change of mastoparan from wasp venom on
binding with phospholipid membrane, FEBS Lett., 152, 227, 1983.
17. Higashijima, T. et al., Mastoparan, a peptide toxin from wasp venom, mimics receptors
by activating GTP-binding regulatory proteins (G proteins), J. Biol. Chem., 263,
6491, 1988.
18. Mousli, M. et al., G protein activation: a receptor-independent mode of action for
cationic amphiphilic neuropeptides and venom peptides, Trends Pharmacol. Sci., 11,
358, 1990.